Company Search:
Advanced Search
Sponsored Links
Dechra Pharmaceuticals PLC Company Snapshot
Dechra Pharmaceuticals PLC operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dechra Pharmaceuticals PLC with three other companies in this sector in the United Kingdom: Vectura Group PLC (2016 sales of £168.25 million [US$218.50 million] of which 100% was Pharmaceutical Prod), Amarin Corporation PLC (£96.76 million [US$125.66 million] of which 100% was Research&Development), and Alliance Pharma Plc (£97.49 million [US$126.61 million] of which 100% was Pharmaceuticals).

Sales Analysis. Dechra Pharmaceuticals PLC reported sales of £247.56 million (US$321.51 million) for the fiscal year ending June of 2016. This represents an increase of 21.7% versus 2015, when the company's sales were £203.48 million. This was the third consecutive year of growth at Dechra Pharmaceuticals PLC. Sales of Na Pharmaceuticals saw an increase that was more than double the company's growth rate: sales were up 68.4% in 2016, from £34.87 million to £58.73 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Dechra Pharmaceuticals PLC
  Stock Performance Chart for Dechra Pharmaceuticals PLC
  Stock Data: Recent Stock Performance:
  Current Price (7/21/2017): 1,742.00p
(Figures in Pounds Sterling)
1 Week 4.7%   13 Weeks -3.3%  
4 Weeks 7.3%   52 Weeks 37.3%  
Dechra Pharmaceuticals PLC Key Data:
  Ticker: DPH Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 247,562,000
(Year Ending Jan 2017).
Employees: 1,308
  Currency: Pounds Sterling Market Cap: 1,623,173,930
  Fiscal Yr Ends: June Shares Outstanding: 93,178,756
  Share Type: Ordinary Closely Held Shares: 2,301,064
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.